» Articles » PMID: 33671801

The Antiproliferative and Apoptotic Effect of a Novel Synthesized -Triazine Dipeptide Series, and Toxicity Screening in Zebrafish Embryos

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2021 Mar 6
PMID 33671801
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Several derivatives containing morpholine/piperidine, anilines, and dipeptides as pending moieties were prepared using -triazine as a scaffold. These compounds were evaluated for their anticancer activity against two human breast cancer cell lines (MCF-7 and MDA-MB-231), a colon cancer cell line (HCT-116), and a non-tumorigenic cell line (HEK 293). Tamoxifen was used as a reference. Animal toxicity tests were carried out in zebrafish embryos. Most of these compounds showed a higher activity against breast cancer than colon cancer. Compound -which contains morpholine, aniline, and glycylglycinate methyl ester-showed a high level of cytotoxicity against MCF-7 cells with IC values of less than 1 µM. This compound showed a much lower level of toxicity against the non-tumorigenic HEK-293 cell line, and in the in vivo studies using zebrafish embryos. Furthermore, it induced cell cycle arrest at the G2/M phase, and apoptosis in MCF-7 cells. On the basis of our results, emerges as a potential candidate for further development as a therapeutic drug to treat hormone receptor-positive breast cancer.

Citing Articles

CuO nanoparticles for green synthesis of significant anti-Helicobacter pylori compounds with in silico studies.

Shehab W, Elsayed D, Abdel Hamid A, Assy M, Mouneir S, Hamed E Sci Rep. 2024; 14(1):1608.

PMID: 38238369 PMC: 10796945. DOI: 10.1038/s41598-024-51708-1.


Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint Inhibitors.

Bestion E, Raymond E, Mezouar S, Halfon P Cells. 2023; 12(13).

PMID: 37443736 PMC: 10341243. DOI: 10.3390/cells12131702.


Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)--triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades.

Shawish I, Barakat A, Aldalbahi A, Malebari A, Nafie M, Bekhit A ACS Omega. 2022; 7(28):24858-24870.

PMID: 35874229 PMC: 9301957. DOI: 10.1021/acsomega.2c03079.


Recent Advances in the Biological Activity of s-Triazine Core Compounds.

Maliszewski D, Drozdowska D Pharmaceuticals (Basel). 2022; 15(2).

PMID: 35215333 PMC: 8875733. DOI: 10.3390/ph15020221.

References
1.
Aggelis V, Johnston S . Advances in Endocrine-Based Therapies for Estrogen Receptor-Positive Metastatic Breast Cancer. Drugs. 2019; 79(17):1849-1866. DOI: 10.1007/s40265-019-01208-8. View

2.
El-Faham A, Zainab Al Marhoon , Abdel-Megeed A, Albericio F . OxymaPure/DIC: an efficient reagent for the synthesis of a novel series of 4-[2-(2-acetylaminophenyl)-2-oxo-acetylamino] benzoyl amino acid ester derivatives. Molecules. 2013; 18(12):14747-59. PMC: 6269765. DOI: 10.3390/molecules181214747. View

3.
Sieber S, Grossen P, Bussmann J, Campbell F, Kros A, Witzigmann D . Zebrafish as a preclinical in vivo screening model for nanomedicines. Adv Drug Deliv Rev. 2019; 151-152:152-168. DOI: 10.1016/j.addr.2019.01.001. View

4.
Xia L, Zheng L, Zhou J . Transcriptional and morphological effects of tamoxifen on the early development of zebrafish (Danio rerio). J Appl Toxicol. 2015; 36(6):853-62. DOI: 10.1002/jat.3257. View

5.
Katzenellenbogen J, Mayne C, Katzenellenbogen B, Greene G, Chandarlapaty S . Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. Nat Rev Cancer. 2018; 18(6):377-388. PMC: 6252060. DOI: 10.1038/s41568-018-0001-z. View